Hi,成都瑞芬思德丹生物科技有限公司欢迎您!

专业研发

量身定制天然药物活性成分

梓苷

Catalposide
Z-126
梓实糖苷;梓醇6 -对羟基苯甲酸酯,(羟基苯甲酰基)梓醇 展开
b-D-Glucopyranoside,(1aS,1bS,2S,5aR,6S,6aS)-1a,1b,2,5a,6,6a-hexahydro-6-[(4-hydroxybenzoyl)oxy]-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl;b-D-Glucopyranoside,(1aS,1bS,2S,5aR,6S,6aS)-1a,1b,2,5a,6,6a-hexahydro-6-[(4-hydroxybenzoyl)oxy]-1a-(hydroxymethyl)oxireno[4,5;CATALPIN;Catalposide;CATALPOSIDE(RG);Einecs 229-789-1;hydroxybenzoylcatalpol;[ ""];Hydroxybenzoyl catalpol;NS00046512;CATALPOL 6-P-HYDROXYBENZOATE;beta-D-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-((4-hydroxybenzoyl)oxy)-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1aS-(1a-alpha,1b-beta,2-beta,5a-beta,6-beta,6a-alpha))-;MS-28964;AKOS032962388;HY-N3552;BDBM50429458;CATALPOSIDE [MI];CS-0023820;6736-85-2;DTXSID30986621;7KD7K3964H;E88694;UNII-7KD7K3964H;.BETA.-D-GLUCOPYRANOSIDE, (1AS,1BS,2S,5AR,6S,6AS)-1A,1B,2,5A,6,6A-HEXAHYDRO-6-((4-HYDROXYBENZOYL)OXY)-1A-(HYDROXYMETHYL)OXIRENO(4,5)CYCLOPENTA(1,2-C)PYRAN-2-YL;NCGC00347848-02;CHEMBL2332354;1a(S)alpha,1bbeta,2beta,5abeta,6beta,6aalpha-Hexahydro-6-((4-hydroxybenzoyl)oxy)-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl beta-D-glucopyranoside;Benzeneacetonitrile, .alpha.-bromo-4-chloro-;(HYDROXYBENZOYL)CATALPOL;SCHEMBL419598;Benzoic acid, 4-hydroxy-, octahydro-2a,6-dihydroxy-2H-1,7-dioxacyclopent[cd]inden-4-yl ester, [2aS-(2aalpha,4alpha,4aalpha,6alpha,7aalpha,7balpha)]-;NSC-30052;[2-(Hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] 4-hydroxybenzoate;[(1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] 4-hydroxybenzoate;[2-(Hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl] 4-hydroxybenzoate;[2-(hydroxymethyl)-10-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.0^{2,4]dec-7-en-5-yl] 4-hydroxybenzoate;FT-0603074;(Hydroxybenzoyl)catalpol; Catalpol 6-p-hydroxybenzoate;NSC30052;(1S,2S,4S,5S,6S,10S)-2-(Hydroxymethyl)-10-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0,]dec-7-en-5-yl 4-hydroxybenzoic acid;((1S,2S,4S,5S,6R,10S)-2-(hydroxymethyl)-10-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-3,9-dioxatricyclo(4.4.0.02,4)dec-7-en-5-yl) 4-hydroxybenzoate;((1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-2,5a,6,6a-tetrahydro-1bH-oxireno(5,6)cyclopenta(1,3-c)pyran-6-yl) 4-hydroxybenzoate;[(1aS,1bS,2S,5aR,6S,6aS)-1a-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5a,6,6a-tetrahydro-1bH-oxireno[5,6]cyclopenta[1,3-c]pyran-6-yl] 4-hydroxybenzoate;(1S,2S,4S,5S,6S,10S)-2-(Hydroxymethyl)-10-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)-3,... 展开
6736-85-2
C22H26O12
482.43
本公司提供产品推荐用于定性对照、药理研究;不建议定量、标准含测、药品原料使用
本公司所提供质检报告仅证明产品纯度、核磁结构;不做溶残分析及含量确认。
货号 品牌 包装 市场价 会员价 库存 数量 购物车
Z-126-20mg 瑞芬思 20mg 询价
询价
急速发货 正品保障 提供发票

瑞芬思标准物质-专业中药对照品标准品供应商。

 

 

【植物来源】:地黄

 

【性   状】:白色结晶粉末

 

【溶解性】:可溶于甲醇、乙醇、DMSO等有机溶剂;

 

【药理作用】:抗痉挛、降血糖、抗饱胀感、抗肿瘤、利尿

 

【检测方法】:待更新

 

【鉴定方法】:NMR;Ms

 

【储存方式】:避光 密闭2-8℃ 

 

【类   别】:环烯醚萜苷类

 

【供   货】:可根据客户需要包装、定制、批量生产!

象形图:
警示语:
Class:
警告声明:
UNub:
危险声明:
Packing Group:
搜索质检报告(COA)
货号(Item Number):
批号(Lot Number):

如何获取质检证书(COA)?

请输入货号(Item Number)和一个与之匹配的批号(Lot Number) 请点击查看这个标签例子...
暂无相关文献!